Frazier Life Sciences Management L.P. Buys 438,274 Shares of Maze Therapeutics, Inc. $MAZE
Frazier Life Sciences Management L.P. grew its position in shares of Maze Therapeutics, Inc. (NASDAQ:MAZE - Free Report) by 10.6% during the 2nd quarter, according to its most recent 13F filing with...